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Abstract	
	Autoimmune	 encephalomyelitis	 is	 a	 disease	 of	 the	 central	 nervous	 system	 that	 can	develop	when	an	 initial	peripheral	 inflammatory	stimulus	 is	 followed	by	 infiltration	and	 reactivation	of	T	 lymphocytes	 in	 the	 central	nervous	 system.	We	here	 report	 a	crucial	role	for	coronin	1,	which	is	essential	for	maintenance	of	the	naïve	T	cell	pool,	for	the	development	of	murine	experimental	autoimmune	encephalomyelitis	(EAE),	a	model	for	multiple	sclerosis.	In	the	absence	of	coronin	1,	immunization	with	MOG35-55	peptide	 largely	 failed	 to	 induce	 EAE	 symptoms,	 despite	 normal	 mobilization	 of	leukocyte	subsets	in	the	blood	as	well	as	effector	cytokine	expression	comparable	to	wild-type	 T	 cells	 upon	 polyclonal	 stimulation.	 Susceptibility	 of	 coronin	 1-deficient	mice	to	EAE	induction	was	restored	by	transfer	of	wild-type	CD4+	T	cells,	consistent	with	 a	 failure	of	 coronin	1-deficient	mice	 to	 generate	 a	MOG-specific	T	 effector	 cell	response.	Importantly,	while	coronin	1-deficient	regulatory	T	cells	(Tregs)	showed	a	suppressor	 activity	 comparable	 to	wild-type	Tregs,	 Treg	 depletion	 failed	 to	 restore	EAE	 development	 in	 coronin	 1-deficient	 animals.	 These	 results	 suggest	 a	 hitherto	unrecognized	 role	 of	 naïve	 T	 cells	 in	 the	 development	 of	 autoimmune	encephalomyelitis	and	reveal	coronin	1	as	a	crucial	modulator	of	EAE	induction.		
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Introduction	
	The	 immune	system	has	evolved	mechanisms	to	respond	to	a	diverse	set	of	 foreign	antigens	while	minimizing	the	risk	for	auto-reactivity.	T	cells	play	an	important	role	in	 ensuring	 a	 successful	 immune	 response;	 however,	 under	 still	 ill	 defined	circumstances,	 T	 cells	 can	 cause	 harm	 to	 the	 body’s	 own	 constituents	 and	mediate	autoimmune	 pathology.	 Multiple	 sclerosis	 (MS)	 is	 an	 inflammatory	 demyelinating	brain	disease,	in	which	autoreactive	T	cells	are	thought	to	play	a	major	role	in	disease	pathogenesis	(for	review	see	(1)).	This	immune	response	leads	to	an	inflammation	in	the	central	nervous	system	(CNS)	and	subsequent	demyelination	and	axonal	 injury.	Experimental	 autoimmune	 encephalomyelitis	 (EAE)	 is	 the	 commonly	 used	 animal	model	to	study	immunopathogenesis	of	MS.	To	induce	active	EAE,	C57BL/6	mice	are	immunized	with	peptides	of	a	CNS-derived	autoantigen	e.g.	myelin	oligoglycoprotein,	MOG	(2,	3).	In	this	form	of	EAE,	MOG-specific	naïve	T	cells	are	activated	and	expand	during	 the	 initiation	phase	of	 the	 immune	 response	 in	 the	draining	 lymph	node.	At	later	time	points	the	expanded	T	cells	invade	the	CNS	where	they	are	reactivated	by	local	 and	 infiltrating	 antigen-presenting	 cells	 (4,	 5)	 and	 initiate	 the	 recruitment	 of	inflammatory	cells	such	as	neutrophils	and	macrophages	to	induce	the	effector	phase.	In	 this	 rodent	 model	 of	 EAE,	 inflammation	 predominantly	 targets	 the	 spinal	 cord	resulting	in	the	classic	symptoms	of	ascending	flaccid	paralysis.	While	 Th1	 cells	were	 believed	 to	 be	 the	main	 effector	 cell	 subset	 in	 this	 particular	EAE	 model,	 recent	 work	 has	 highlighted	 the	 importance	 of	 Th17	 cells	 for	 the	pathology	of	EAE.	To	date,	several	studies	indicate	that	Th1	as	well	as	Th17	cells	can	induce	 autoimmunity	 in	 the	 CNS	 and	 play	 complementary	 roles	 in	 pathogenesis	 of	EAE	(6,	7),	while	Th2	response	are	protective	(8,	9).	In	contrast	to	these	effector	T	cell	subsets,	regulatory	T	cells	have	been	 implicated	 in	the	prevention	and	resolution	of	EAE.	Increasing	the	number	of	Tregs	has	shown	beneficial	effects	on	EAE	pathology,	while	decreasing	Treg	numbers	worsened	disease	outcome	(10-13).	 It	 thus	appears	that	 the	 balance	 between	different	T	 cell	 subsets,	 in	 particular	Th1,	 Th17,	 Th2	 and	Tregs	may	be	dictating	disease	outcome	following	immunization	with	myelin-derived	peptides.	
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In	healthy	mice,	the	different	T	cell	populations	such	as	naïve,	memory	and	regulatory	T	 cells	 occupy	 their	 own	niche	 in	 the	periphery,	 and	T	 cell	 numbers	 are	 fairly	well	maintained.	 The	 mechanisms	 underlying	 the	 maintenance	 of	 the	 peripheral	 T	 cell	pool	 are	 incompletely	 understood.	 Naïve	 T	 cell	 survival	 in	 the	 periphery	 seems	 to	depend	 on	 continuous	 low-level	 stimulation	 of	 their	 T	 cell	 receptor	 (TCR)	 by	 self-MHC	molecules	in	secondary	lymphoid	organs	as	well	as	IL-7	signaling	(reviewed	in	(14)).	 In	 the	 absence	 of	 appropriate	 stimuli	 such	 as	 in	 mice	 lacking	 major	histocompatibility	 complex	 (MHC)	 expression,	 the	 naïve	 T	 cell	 pool	 is	 greatly	diminished	and	lymphopenia	develops,	that	favors	the	enrichment	of	memory-like	T	cells	(15-18).	Similarly,	ablation	of	the	T	cell	receptor	expression	leads	to	a	reduction	in	 peripheral	 T	 cells,	 underscoring	 that	 peripheral	 T	 cell	 survival	 relies	 on	 TCR-dependent	stimulation.		Recently,	coronin	1	(also	known	as	P57	or	TACO,	for	tryptophan	aspartate	containing	coat	protein)	has	been	identified	as	a	molecule	essential	for	naïve	T	cell	maintenance	in	 the	 periphery	 (19-23).	 Coronin	 1,	 which	 is	 a	 leukocyte-specific	 molecule	 of	 the	coronin	protein	family	of	WD	repeat	containing	proteins,	is	essential	for	intracellular	calcium	 mobilization	 following	 T	 cell	 receptor	 stimulation	 and	 survival	 of	 naïve	 T	cells.	 Mice	 lacking	 coronin	 1	 have	 strongly	 reduced	 naïve	 T	 cell	 numbers	 in	 the	periphery,	 while	 thymic	 cellularity	 and	 selection	 is	 relatively	 normal	 (19-23).	Interestingly,	despite	strongly	reduced	naïve	T	cell	numbers	and	the	observed	in	vitro	activation	defect,	coronin	1-deficient	mice	show	relatively	normal	antibody	responses	to	thymus-dependent	and	independent	antigens	(24).		We	 here	 show	 that	 upon	 immunization	 with	 MOG35-55	 peptide,	 coronin	 1-deficient	mice	are	 largely	resistant	to	EAE.	Failure	to	 induce	EAE	in	the	absence	of	coronin	1	occurred	despite	the	fact	that	upon	polyclonal	stimulation,	coronin	1-deficient	CD4+	T	cells	 expressed	 effector	 cytokines	 comparable	 to	 wild-type	 T	 cells.	 The	 transfer	 of	wild-type	 CD4+	 T	 cells	 prior	 to	 EAE	 induction	 could	 restore	 susceptibility	 to	 EAE.	Furthermore,	despite	normal	regulatory	T	cell	 function	 in	 the	absence	of	coronin	1,	Tregs	were	not	involved	in	EAE	resistance.	These	results	suggest	an	important	role	for	coronin	1	in	the	development	of	EAE	and	furthermore	reveal	the	importance	of	an	intact	naïve	T	cell	pool	as	a	prerequisite	for	autoimmune	induction.	
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Material	and	methods		
Mice		Coronin	 1-deficient	 mice	 were	 generated	 in	 our	 laboratory	 as	 described	 (25)	 and	backcrossed	 to	 C57BL/6	 for	 eight	 generations.	 The	 corresponding	 littermates	(knockout	 and	 wild-type)	 were	 bred	 in-house	 as	 homozygous	 lines.	 For	 the	 EAE	experiments	females	of	age	8	to	16	weeks	were	used.	All	experiments	were	approved	by	the	Kantonales	Veterinäramt	Basel-Stadt.			
Induction	of	active	EAE	EAE	was	induced	by	active	immunization	with	MOG35-55	peptide	based	on	established	protocols	 (26,	 27).	 To	 that	 end,	 8-12	 weeks	 old	 the	 mice	 were	 immunized	subcutaneously	 on	 the	 back	 at	 day	 0	 with	 200	 µg	 MOG35-55	 peptide	 (Genscript)	emulsified	in	100	µl	complete	Freund´s	adjuvant	(Sigma)	at	a	final	volume	of	200	µl.	On	day	0	and	2	the	animals	were	injected	with	250	ng	pertussis	toxin	(Sigma)	in	100	µl	 PBS	 intra	 peritoneally.	 In	 some	 experiments,	 wild-type	 CD4+	 T	 cells	 were	transferred	 i.v.	 to	 coronin	1-deficient	mice	 one	day	prior	 to	EAE	 induction.	 For	 the	CD4+	 T	 cell	 sort,	 erythrocyte-depleted	 cell	 suspensions	 of	 lymph	 node	 and	 spleen	from	naïve	wild-type	mice	were	stained	with	anti–CD4-FITC	antibody	(clone	RM4-5,	Biolegend)	 and	 subsequently	 labeled	 with	 anti-FITC	 microbeads	 (Miltenyi	 Biotec).	Thereafter,	 the	CD4+	T	 cells	were	 isolated	using	LS	 columns	 and	magnets	 (Miltenyi	Biotec).	 The	 sort	 purity	 was	 above	 95%	 on	 reanalysis.	 For	 Treg	 depletion	experiments,	the	mice	were	treated	with	0.5	mg	anti-CD25	antibody	(PC61,	purified	according	to	(28))	i.p.	5	and	3	days	before	induction	of	EAE,	which	corresponds	to	day	0.	Wild-type	 and	 coronin	 1-deficient	mice	 not	 treated	with	 antibody	were	 used	 as	controls.	 The	 efficiency	 of	 CD25	 depletion	 was	 monitored	 in	 the	 blood	 by	 flow	cytometry	at	day	-8,	-1	and	7	by	staining	with	an	anti-CD25	antibody	that	recognizes	an	 epitope	 different	 from	 that	 recognized	 by	 PC61	 to	 avoid	 interference	 of	 the	depleting	antibody	with	the	staining.	To	monitor	immune	response	in	peripheral	blood	and	to	determine	the	success	of	T	cell	 transfer	 or	 Treg	 depletion,	 mice	 were	 bled	 prior	 to	 EAE	 induction	 and	 during	disease	 progression.	 Not	 more	 than	 60	 µl	 blood	 was	 taken	 from	 the	 tail	 vein	 by	puncture	with	 a	 22G	 needle	 at	 each	 time	 point	 and	 collected	 in	 heparinized	 tubes.	
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Leukocyte	 counts	 in	 the	 erythrocyte-depleted	 blood	 were	 determined	 with	 a	Neubauer	chamber	and	further	analyses	were	performed	by	flow	cytometry.	Clinical	signs	of	EAE	were	assessed	daily	according	to	the	standard	scoring	protocol	using	the	following	scoring	system:	(29,	30)	0,	no	clinical	signs;	0.5,	tip	tail	weakness;	1,	 tail	 weakness;	 1.5,	 mild	 monoparesis;	 2,	 monoparesis	 or	 monoplegia;	 2.5,	 mild	paraparesis;	 3,	 paraparesis,	 paraplegia	 or	 mild	 hemiplegia;	 3.5,	 paraplegia	 with	spasticity;	4,	quadriparesis;	5,	morbid	stage.	The	mice	were	euthanized	at	score	4	or	when	 a	 clinical	 score	 of	 3.5	 lasted	 for	more	 than	 2	 days.	 In	 some	 experiments,	 the	body	weight	was	determined	as	well.			
Proliferation	analyses,	intracellular	cytokine	expression	and	ELISA	At	 different	 time	 points	 after	 EAE	 induction	 the	 mice	 were	 scarified	 using	 high	concentrations	 of	 CO2	 and	 the	 spleen	 was	 removed	 for	 further	 in	 vitro	 analyses.	Erythrocyte-depleted	 splenocytes	 were	 cultured	 with	 different	 concentrations	 of	MOG35-55	peptide	or	anti-CD3	(1	µg/ml)	and	anti-CD28	(2	µg/ml)	antibodies	in	RPMI-1640	(Sigma)	supplemented	with	MEM	non-essential	amino	acids	(Invitrogen),	1	mM	sodium	pyrovate	 (Sigma),	Penicillin	 (100	units)-Streptomycin	 (100	µg/ml)	 (Sigma),	2-mercaptoethanol	 (Invitrogen),	 10%	 foetal	 bovine	 serum	 (PAA	 laboratories).	 For	proliferation	 analysis,	 splenocytes	 (4x	105	per	well)	were	 cultured	 in	150	µl	 in	 96-well	 round	 bottom	 plates.	 At	 72	 hours	 of	 culture,	 1	 µCi	 [3H]thymidine	 (Hartmann)	was	 added	 per	 well	 and	 the	 cells	 were	 harvested	 16	 hours	 later	 and	 assessed	 for	incorporation	 of	 the	 radioisotope.	 For	 determination	 of	 cytokine	 secretion,	splenocytes	 (2x	 106/ml,	 500µl	 in	 24	 well	 plate)	 were	 stimulated	 with	 50	 µg/ml	MOG35-55	peptide	 for	48	hours	and	 then	 the	 IL-4,	 IFN-g	 and	 IL-17A	concentration	 in	the	 supernatant	 was	 measured	 by	 ELISA	 (Biolegend).	 Intracellular	 cytokines	 were	analyzed	in	vitro	after	4	hours	of	stimulation	with	anti-CD3	and	anti-CD28	antibodies	in	the	presence	of	10µg/ml	brefeldin	A	(Sigma)	for	the	last	2	hours.			
Flow	cytometry		The	 following	 antibodies	were	 used	 for	 staining	 cells	 for	 flow	 cytometric	 analyses:	anti-CD4	Pacific	blue	(Invitrogen),	CD25-PE-Cy7	(clone	PC61,	BD	Biosciences),	CD25-PE	(clone	7D4,	Miltenyi	Biotech),	IL-4-PE	(Biolegend),	IL-17A-APC	(Biolegend),	IFN-g	(Biolegend).	For	Foxp3	detection	the	Foxp3-Alexa	Fluor	647	flow	kit	from	Biolegend	
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was	 used	 und	 the	 staining	 performed	 according	 to	 the	manufacturers	 instructions.	For	 surface	 staining	 the	 cells	 were	 incubated	 with	 the	 labeled	 antibodies	 for	 15	minutes	 on	 ice	 in	 the	 dark	 and	 then	 washed	 once	 with	 PBS/0.5%BSA.	 For	intracellular	 staining,	 cells	were	 first	 stained	 for	 surface	 antigens	 as	 described	 and	then	 fixed	with	2%	paraformaldehyde	 for	20	minutes	at	 room	 temperature.	After	a	washing	 step	with	 PBS/0.5%BSA	 the	 cells	were	 permeabilized	 using	 0.5%	 saponin	(Sigma)	in	PBS/0.5%	BSA	and	stained	in	this	buffer	for	15	minutes	with	anti-cytokine	antibodies	at	 room	temperature.	This	was	 followed	by	one	washing	step	with	0.5%	saponin/PBS/0.5%BSA	 and	 one	 washing	 step	 with	 PBS/0.5%BSA.	 Incubation	 with	FcR	 block	 (anti-CD16/32	 antibody,	 Biolegend)	 was	 included.	 The	 samples	 were	measured	on	a	FACS	Canto	II	(BD	Biosciences)	and	the	data	were	analyzed	with	the	FlowJo	software	(Tree	Star).		
Immunofluorescence	and	microscopy	Spinal	cord	tissue	was	removed,	embedded	in	O.C.T.	Tissue-Tek	(Sakura)	and	frozen	on	dry	ice.	Cryostat	sections	(10	µm)	were	air-dried	for	30	minutes	and	fixed	for	30	minutes	 in	 4%	 paraformaldehyde	 for	 staining	 with	 anti-F4/80	 antibodies	(macrophages	and	microglia),	anti-CD4	(T	cells)	or	anti-coronin	1	antibodies.	Sections	were	first	incubated	for	1h	in	blocking	buffer	(5%	normal	donkey	serum	(NDS),	0.1%	Triton	X-100,	 0.05%	Tween-20)	 followed	by	 incubation	with	 primary	 antibodies	 in	blocking	buffer	overnight	at	4°C.	After	washing	with	PBS	the	sections	were	incubated	with	 the	 secondary	 antibodies	 for	 one	 hour	 at	 room	 temperature.	 Slides	 were	mounted	 with	 Fluorosave	 (Calbiochem)	 and	 kept	 at	 4°C.	 Confocal	 microscopy	 was	performed	 using	 a	 Zeiss	 LSM	 710	microscope	with	 ZEN	 2009	 software	 (Carl	 Zeiss,	Inc.).	 Lesion	 quantification	 was	 done	 using	 the	 Cell^P	 software	 (Olympus).	 Lesion	area	was	determined	by	F4/80	 staining	and	analyzed	using	 three	 sections	 (approx.	cervical	 segment	 6,	 thoracal	 segment	 6	 and	 lumbar	 segment	 1)	 per	 animal.	 Lesion	load	 was	 displayed	 as	 percentage	 of	 whole	 spinal	 cord	 analysed.	 The	 following	antibodies	were	used	for	staining	of	spinal	cord	sections:	anti-F4/80	(kindly	provided	by	 V.H.	 Perry,	 University	 of	 Southhampton,	 (31,	 32),	 anti-CD4	 (clone	 RM4-5,	Biolegend)	and	polyclonal	anti-coronin	1	rabbit	antiserum	(Gatfield	et	al.,	2005).	The	following	 secondary	 antibodies	 were	 used	 (all	 from	 Jackson	 ImmunoResearch	
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Laboratories,	 Inc.):	 donkey-anti-rabbit	 DyLight	 488	 (1:500),	 donkey-anti-rabbit	DyLight	549	(1:500),	donkey-anti-rat-Cy3	(1:500),	donkey	anti-rat-Cy5	(1:500).		
Treg	suppression	assay	T	cell	subsets	were	isolated	from	spleen	and	peripheral	and	mesenteric	lymph	nodes	of	 wild-type	 and	 coronin	 1-deficient	 mice.	 Erythrocyte-depleted	 cell	 suspensions	were	 stained	 with	 anti-CD25	 APC	 and	 anti-CD4	 PE	 antibody	 (Biolegend).	 Prior	 to	sorting	of	CD25+	and	CD25+	CD4+	T	 cells	with	FACS	ARIA	 (BD	Biosciences),	CD4+	T	cells	 were	 isolated	 using	 anti-PE	 microbeads	 and	 a	 magnetic	 separation	 system	(Miltenyi	 Biotec).	 Single	 cell	 suspensions	 from	 C57BL/6	 spleens,	 erythrocyte-lysed	and	 depleted	 of	 CD4+	 and	 CD8+	 T	 cells,	 were	 irraditated	 and	 used	 as	 antigen	presenting	cells	(APCs).	Suppression	assays	were	performed	in	96-well	round	bottom	plates	 (3x	104	CD25-CD4+	 responder	 cells	plus	6x	104	 irradiated	APCs	plus	 titrated	numbers	 of	 CD25+CD4+	Treg	 cells)	 in	 triplicates.	 As	 controls	 CD25+CD4+	 and	CD25-CD4+	 T	 cells	were	 cultured	without	 Tregs.	 The	 cells	were	 stimulated	with	 1	 µg/ml	anti-CD3	antibody	 (clone	2C-11,	Biolegend)	and	pulsed	after	60	hours	 for	16	hours	with	1	µCi	[3H]thymidine	per	well	(Hartmann).			
Statistical	analyses	The	data	represent	the	mean	(±	SD	or	SEM,	indicated	in	the	figure	legends);	FACS	dot	plots	and	microscopic	pictures	show	representative	results.	The	number	of	mice	(n)	used	 per	 experiment	 and	 the	 number	 of	 experiments	 performed	 are	 listed	 in	 each	figure	legend.	Statistically	significance	of	the	ELISA	and	flow	cytometry	results	as	well	as	the	EAE	day	of	onset,	maximal	disease	score	and	lesion	size	was	analyzed	by	Mann-Whitney	statistical	 test	and	 the	EAE	score	and	weight	versus	 time	was	analyzed	by	Wilcoxon	signed	rank	test	using	GraphPad	Prismsoftware	(GraphPad).		
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Results	
	
Role	for	coronin	1	in	the	development	of	EAE		Coronin	1	is	a	leukocyte-specific	regulator	of	Ca2+-dependent	signaling	processes	and	essential	 for	 the	 maintenance	 of	 the	 naïve	 T	 cell	 pool	 in	 the	 periphery	 (19-22).	Despite	diminished	numbers	of	naïve	T	cells	(20),	when	coronin	1-deficient	mice	are	immunized	with	a	variety	of	antigens,	normal	antibody	responses	are	generated	(24).	To	 investigate	 the	 role	 of	 coronin	 1	 in	 the	 pathogenesis	 of	 T	 cell	 mediated	autoimmunity,	coronin	1-deficient	and	wild-type	C57Bl/6	mice	were	immunized	with	MOG35-55	 peptide	 emulsified	 in	 complete	 Freund´s	 adjuvant	 (CFA)	 subcutaneously	together	with	pertussis	toxin	intra	peritonealy	leading	to	induction	of	active	EAE	(see	
materials	and	methods).	The	development	of	clinical	signs	of	disease	was	monitored	over	several	weeks.	 Initial	 signs	of	EAE,	 starting	with	 tail	weakness,	were	observed	ten	days	(on	average	11.6	±	2.7	days)	after	immunization	of	wild-type	mice	while	at	this	 time	 point	 none	 of	 the	 coronin	 1-deficient	 mice	 showed	 any	 signs	 of	 disease	(Figure	 1A).	 Onset	 and	 progression	 of	 disease	 were	 also	 reflected	 by	 weight	 loss	(Figure	 1B).	While	 by	 day	 17,	 all	 wild-type	mice	 had	 developed	 full-blown	 disease	with	a	mean	maximal	clinical	score	of	3.1	±	0.4,	only	two	out	of	32	coronin	1-deficient	mice	 showed	clinical	 signs	of	EAE.	During	 the	entire	period	of	observation,	only	13	out	 of	 32	 coronin	 1-deficient	 mice	 developed	 EAE	 symptoms,	 which	 were	characterized	 by	 a	 significantly	 delayed	 onset	 of	 disease	 (23.6	 ±	 6	 days)	 and	 a	reduction	 in	disease	 severity	 (maximal	 clinical	 score	of	1.8	±	 0.9)	 in	 comparison	 to	wild-type	mice	(Figure	1C,	D	and	E).	Prolonged	monitoring	of	the	EAE	development	up	 to	60	days	 revealed	a	 continuous	 slow	progressing	 remission	 in	wild-type	mice,	whereas	clinical	scores	of	 the	coronin	1-deficient	mice	stayed	 low	also	at	 these	 late	time	points	after	immunization	(Suppl.	Figure	1).		To	 analyze	 the	 relative	 lesion	 size	 in	 spinal	 cords	 from	 immunized	 wild-type	 and	coronin	1-deficient	animals,	histological	sections	were	stained	with	F4/80,	a	marker	for	 activated	 microglia/macrophages.	 Consistent	 with	 the	 aforementioned	 clinical	EAE	symptoms,	all	wild-type	mice	showed	massive	inflammatory	lesions	in	the	spinal	cord;	in	contrast,	only	some	coronin	1-deficient	mice	developed	inflammatory	lesions	(Figure	 1F).	 Furthermore,	 also	 confirming	 the	 clinical	 observations,	 the	 lesions	 of	
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coronin	 1-deficient	 spinal	 cord	 were	 smaller	 in	 size	 and	 observed	 mainly	 in	 the	lumbar	 part,	which	 reflects	 less	 progressed	 disease	 (Figure	 1F).	We	 conclude	 from	these	results	that	coronin	1-deficient	mice	are	largely	resistant	to	EAE	induction.		
Immune	responses	during	EAE	development	in	the	presence	and	absence	of	coronin	1	To	monitor	 immune	 responses	 during	 EAE	 initiation	 and	 progression	 in	 wild-type	and	 coronin	1-deficient	mice,	 blood	 samples	were	 taken	before	 and	at	 several	 time	points	after	 immunization.	Determination	of	 leukocyte	cell	counts	 in	the	blood	after	lysis	 of	 erythrocytes	 revealed	 a	 strong	 increase	 in	 cellularity	 in	 both	wild-type	 and	coronin	1-deficient	mice	upon	immunization,	while	non-immunized	mice	analyzed	in	parallel	 showed	 no	 changes	 in	 their	 immune	 cell	 composition	 in	 blood	 (Figure	 2).	Specifically,	immunization	led	to	a	comparable	increase	in	leukocyte,	granulocyte	and	lymphocyte	counts	(Figure	2A	and	B)	as	well	as	CD4+	T	cells	(Figure	2C)	in	both	mice	strains,	 although	 overall	 coronin	 1-deficient	mice	 had	 lower	 numbers	 of	 leukocyte	subsets	compared	to	wild-type	mice.	These	results	suggest	an	equal	mobilization	and	activation	of	immune	cells	in	the	presence	and	absence	of	coronin	1	as	a	consequence	of	 immunization,	 independent	 of	 the	 development	 of	 signs	 of	 autoimmune	encephalomyelitis.	Since	 upon	 immunization	 both	 in	 the	 presence	 as	 well	 as	 absence	 of	 coronin	 1	changes	in	immune	cell	composition	in	blood	were	observed,	we	addressed	whether	the	 resistance	 to	EAE	 induction	 in	 the	absence	of	 coronin	1	can	be	explained	by	an	altered	cytokine	response.	To	that	end,	the	ability	of	coronin	1-deficient	CD4+	T	cells	to	produce	 the	Th1-cytokine	 IFN-g,	 the	Th17-cytokine	 IL-17A	and	 the	Th2-cytokine	IL-4	 was	 analyzed	 upon	 polyclonal	 stimulation	 with	 anti-CD3/CD28	 antibodies	 in	
vitro.	Interestingly,	coronin	1-deficient	mice	had	equal	or	even	increased	numbers	of	IFN-g,	IL-17A	and	IL-4-positive	CD4+	T	cells	in	comparison	to	wild-type	mice	(Figure	2D).	 Of	 note	 is	 the	 IL-4-expression	 that	 was	 significantly	 increased	 in	 coronin	 1-deficient	as	compared	to	wild-type	CD4+	T	cells,	both	in	naïve	as	well	as	immunized	wild-type	and	coronin	1-deficient	mice.	However,	immunization	resulted	in	elevated	expression	 of	 all	 analyzed	 cytokines	 in	 both	 mice	 strains.	 Thus,	 the	 capability	 to	express	cytokines	upon	polyclonal	stimulation	ex	vivo,	 is	similar	between	coronin	1-deficient	 and	wild-type	CD4+	T	 cells,	 and	 therefore	 cannot	 explain	 the	 resistance	of	the	coronin	1-deficient	mice	to	EAE	induction.	
		 11	
We	next	determined	whether	the	observed	resistance	of	coronin	1-deficient	mice	to	EAE	 induction	 was	 due	 to	 defective	 peripheral	 T	 cell	 responses	 to	 the	 initial	immunization	with	MOG35-55	peptide.	MOG-specific	immune	responses	were	analyzed	
ex	 vivo	 at	 different	 time	 points	 after	 immunization.	 Cytokine	 expression	 as	well	 as	proliferation	 was	 determined	 at	 day	 6,	 12,	 16	 and	 at	 day	 40	 after	 immunization,	reflecting	 time	 points	 before	 disease	 induction,	 at	 time	 of	 disease	 induction,	 at	 the	peak	of	clinical	signs	and	during	chronic	disease	state,	respectively.	While	coronin	1-deficient	mice	did	not	show	any	signs	of	EAE	up	to	day	16,	some	of	the	wild-type	mice	had	already	developed	disease	symptoms	at	day	12,	and	all	of	them	by	day	16	(Figure	1	and	asterisks	in	Figure	3A).	Polyclonal	re-stimulation	in	vitro	at	the	indicated	time	points	 revealed	 that	 the	 frequency	 and	 cell	 counts	 of	 IFN-g	 and	 IL-17A-expressing	CD4+	 T	 cells	 increased	 in	 wild-type	 as	 well	 as	 in	 coronin	 1-deficient	 mice	 upon	immunization	 (Suppl.	 Figure	 2).	 However,	while	 the	 cytokine	 expression	 peaked	 in	wild-type	 mice	 around	 day	 12,	 the	 number	 of	 cytokine-positive	 CD4+	 T	 cells	 of	coronin	 1-deficient	 mice	 increased	 progressively,	 indicating	 different	 kinetics	 of	cytokine	 induction	between	wild-type	and	coronin	1-deficient	mice.	The	analyses	of	MOG-specific	 cytokine	 expression	 by	 ELISA	 revealed	 that	 similar	 to	 the	 results	 of	polyclonal	 cytokine	 expression,	 coronin	 1-deficient	 CD4+	 T	 cells	 showed	 delayed	MOG-specific	 cytokine	 responses.	 But	 in	 contrast	 to	 the	 cytokine	 expression	 upon	polyclonal	 stimulation,	 IFN-g	 and	 IL-17A	 secretion	 was	 overall	 lower	 in	 MOG-stimulated	splenocyte	cultures	 from	coronin	1-deficient	mice	(Figure	3A).	However,	some	 of	 the	 immunized	 coronin	 1-deficient	 mice	 secreted	 IFN-g	 and	 IL-17A	 upon	stimulation	 with	 MOG	 at	 levels	 as	 high	 as	 wild-type	 mice;	 but	 not	 in	 all	 of	 those	coronin	1-deficient	animals	a	correlation	with	the	clinical	score	was	observed.	This	is	exemplified	 by	 an	 increased	 IL-17A	 secretion	 in	 two	 mice	 without	 any	 signs	 of	disease	(Figure	3A).	In	contrast	to	the	high	IL-4-expression	observed	upon	polyclonal	stimulation	(Figure	2D	and	Suppl.	Figure	2),	in	none	of	the	samples	any	MOG-specific	IL-4	was	detected	(data	not	shown).		To	 analyze	 the	 MOG-specific	 proliferative	 response,	 splenocytes	 from	 immunized	wild-type	 and	 coronin	 1-deficient	mice	were	 isolated	 at	 different	 time	 points	 after	immunization	 and	 stimulated	 ex	 vivo	with	 either	MOG35-55	 peptide	 or	 anti-CD3	 and	anti-CD28	 antibodies.	 None	 of	 the	 mice,	 neither	 wild-type	 nor	 coronin	 1-deficient,	
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showed	MOG-induced	proliferation	when	analyzed	at	day	six	after	immunization	or	if	immunized	with	 CFA	 solely	 (Figure	 3B	 and	 data	 not	 shown).	 Overall,	MOG-specific	proliferation	 of	 coronin	 1-deficient	 splenocytes	 was	 greatly	 reduced	 in	 contrast	 to	splenocytes	 isolated	 from	 immunized	 wild-type	 mice,	 which	 showed	 a	 dose-dependent	proliferation,	which	was	strongest	at	onset	of	EAE	(day12,	Figure	3B).	In	contrast	 to	 the	 diminished	 MOG-induced	 proliferation	 of	 coronin	 1-deficient	splenocytes,	proliferation	upon	polyclonal	stimulation	was	equivalent	to	that	of	wild-type	 splenocytes,	 especially	 at	 later	 time	 points	 after	 immunization.	 Interestingly,	coronin	 1-deficient	 splenocytes	 showed	 less	 proliferation	 upon	 polyclonal	stimulation	 than	 wild-type	 cells	 at	 day	 6	 and	 day	 12	 after	 immunization,	 but	 this	difference	 was	 not	 observed	 anymore	 at	 day	 16,	 suggesting	 that	 immunization	increased	the	proliferation	capacity	of	coronin	1-deficient	T	cells	to	wild-type	levels.			
Immune	cell	 infiltration	in	spinal	cords	of	wild-type	and	coronin	1-deficient	mice	upon	
induction	of	active	EAE	Experimental	 autoimmune	 encephalomyelitis	 is	 initiated	 by	 infiltration	 of	 MOG-specific	CD4+	T	cells	into	the	central	nervous	system,	where	they	subsequently	induce	the	 recruitment	 of	 other	 immune	 cells.	 To	 analyze	 time-dependent	 infiltration	 of	immune	 cells	 into	 the	 spinal	 cord	 of	wild-type	 and	 coronin	 1-deficient	mice,	 active	EAE	was	 induced	 as	 described	 and	 spinal	 cord	 sections	were	 analyzed	 at	 different	time-points	 thereafter	 by	 histology.	 No	 infiltration	 of	 immune	 cells	 was	 observed	before	disease	onset	 (day	6),	 but	 an	 increasing	number	of	 infiltrating	 immune	cells	(F4/80+	macrophages	and	CD4+	T	cells)	were	detected	at	day	12	and	16	in	the	spinal	cords	 of	 wild-type	 but	 not	 coronin	 1-deficient	 mice	 (Figure	 4,	 lesions	 marked	 by	arrowheads).	In	contrast,	no	infiltration	was	visible	in	coronin	1-deficient	mice	at	any	of	those	time	points.	Coronin	1-positive	leukocytes	were	abundantly	present	in	spinal	cord	lesions	of	wild-type	mice,	while	the	coronin	1	antibody	did	not	stain	the	remaining	area	of	the	spinal	cord	 sections	 (Figure	 4).	 Overall,	 the	 degree	 of	 immune	 cell	 infiltration	 correlated	with	the	degree	of	disease	severity	in	both	mice	strains.				
EAE	development	in	coronin	1-deficient	mice	after	transfer	of	wild-type	CD4+	T	cells	and	
subsequent	immunization	with	MOG35-55	peptide	
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To	analyze	whether	the	resistance	of	coronin	1-deficient	mice	towards	EAE	is	T	cell	intrinsic,	CD4+	T	cells	isolated	from	naïve	wild-type	mice	were	adoptively	transferred	to	 coronin	 1-deficient	 mice	 prior	 to	 immunization	 with	 MOG35-55	 peptide.	 The	presence	of	the	transferred	wild-type	CD4+	T	cells	in	the	blood	of	coronin	1-deficient	mice	was	monitored	by	flow	cytometry	(Suppl.	Figure	3).	While	the	adoptive	transfer	of	one	and	five	million	wild-type	cells	did	not	and	the	transfer	of	ten	million	did	only	slightly	change	the	EAE	outcome,	the	transfer	of	twenty	million	wild-type	CD4+	T	cells	restored	EAE-susceptibility	in	all	coronin	1-deficient	recipients	(with	the	exception	of	one	mouse	that	lost	the	transferred	cells;	Suppl.	Figure	3	and	Figure	5).	The	presence	of	 twenty	million	 wild-type	 CD4+	 T	 cells	 in	 coronin	 1-deficient	 mice	 increased	 the	average	 disease	 incidence	 from	 43%	 to	 100%,	 the	 average	 maximal	 clinical	 score	from	1.3	 to	2.8	and	 the	average	day	of	onset	 from	22.7	 to	17.8	 (Table	 I).	Following	transfer	of	wild	 type	CD4+	T	cells,	 the	disease	outcome	showed	a	mixed	phenotype:	four	 out	 of	 six	mice	developed	 signs	 of	 EAE	 that	were	 equal	 in	 severity	 and	day	of	onset	to	that	of	wild-type	mice,	while	two	recipients	developed	EAE,	which	resembled	the	 lower	 grade	 disease	 observed	 for	 coronin	 1-deficient	 mice.	 We	 conclude	 from	these	 results	 that	 the	 resistance	 of	 coronin	 1-deficient	 mice	 to	 EAE	 induction	 is	caused	by	a	defective	T-cell	response.		
	
Frequency	and	functionality	of	regulatory	T	cells	in	the	presence	and	absence	of	coronin	
1	Development	of	autoimmune	encephalomyelitis	depends	on	the	activation,	expansion	and	 migration	 of	 myelin-specific	 CD4+	 T	 cells	 into	 the	 CNS	 and	 is	 controlled	 by	regulatory	 T	 cells	 that	 suppress	 autoreactive	 T	 cell	 responses	 (reviewed	 by	 (33)).	Given	the	severely	depressed	EAE	responses	in	coronin	1-deficient	mice,	the	impact	of	 coronin	 1-deficiency	 on	 the	 number	 and	 functionality	 of	 Tregs	was	 investigated.	Flow	cytometric	analyses	revealed	an	increased	frequency	of	FOXP3-positive	(CD25+	and	CD25-)	CD4+	T	 cells	 in	peripheral	 lymphoid	organs	of	 coronin	1-deficient	mice,	while	CD25+	CD4+	effector	T	cells	numbers	were	comparable	between	wild-type	and	coronin	 1-deficient	 mice	 (Figure	 6A).	 However,	 the	 total	 Treg	 counts	 were	approximately	half	of	that	of	wild-type	mice,	likely	as	a	result	of	the	overall	reduced	CD4+	T	cell	counts	in	coronin	1-deficient	mice.	
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To	 determine	 the	 suppressive	 function	 of	 coronin	 1-deficient	 Tregs,	 an	 in	 vitro	suppression	 assay	was	performed	with	FACS-sorted	CD25+	 and	CD25-	CD4+	T	 cells.	The	results	revealed	that	coronin	1-deficient	CD25+CD4+	T	cells	were	anergic	similar	to	 wild-type	 CD25+CD4+	 T	 cells	 and	 did	 suppress	 the	 proliferation	 of	 CD25-CD4+	responder	T	cells	 in	 the	co-cultures	 to	a	 similar	degree	 (Figure	6B).	To	address	 the	contribution	 of	 Tregs	 to	 the	 increased	 EAE	 resistance	 observed	 for	 coronin	 1-deficient	mice,	Tregs	were	depleted	in	both	wild-type	and	coronin	1-deficient	mice	by	injection	 of	 the	 anti-CD25	 antibody	 PC61	 accordingly	 to	 the	 treatment	 schedule	shown	 in	 Suppl.	 Figure	 4.	 The	 efficiency	 of	 the	 treatment	 was	 monitored	 by	 flow	cytometry	 of	 blood	 samples	 before	 and	 at	 two	 time	 points	 after	 injection	 of	 the	depleting	antibody.	PC61	treatment	led	to	a	strong	decrease	of	CD25+CD4+	T	cells	as	well	as	Foxp3+CD4+	T	cells	(CD25+	and	CD25-)	in	coronin	1-deficient	as	well	as	wild-type	 mice	 that	 was	 observed	 already	 one	 week	 after	 treatment	 and	 became	more	evident	later	(Suppl.	Figure	4).	While	Treg	depletion	resulted	in	a	more	severe	EAE	in	wild-type	mice	 compared	 to	mice	 that	were	 not	 treated	with	 antibodies,	 it	 had	 no	effect	on	disease	severity	of	coronin	1-deficient	mice	that	remained	resistant	to	EAE	induction	(Figure	6C).	Thus,	these	results	indicate	that	resistance	to	EAE	induction	in	the	absence	of	coronin	1	 is	not	due	to	deregulated	Treg	response	but	 is	more	 likely	caused	by	a	disturbed	naïve	T	cell	priming.	
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Discussion		Susceptibility	to	autoimmune	encephalomyelitis	as	well	as	multiple	sclerosis	requires	activation	of	myelin-specific	T	cells	that	have	escaped	central	tolerance	(reviewed	in	(34)).	It	is	believed	that	those	autoreactive	T	cells	are	present	in	the	peripheral	naïve	T	cell	pool	in	a	state	of	ignorance	(35).	However,	under	certain	circumstances,	these	cells	 can	 become	 activated	 and	 differentiate	 into	 effector	 T	 cells	 that	 then	 acquire	access	 to	 the	 central	nervous	 system.	The	 contribution	of	 the	naïve	T	 cell	 pool	 size	and	 composition	 for	 the	 development	 of	 experimental	 autoimmune	encephalomyelitis	 (EAE)	 is	 currently	 not	 well	 defined.	 We	 here	 show	 that	 mice	lacking	 coronin	1,	which	possess	 a	drastically	 reduced	peripheral	naïve	T	 cell	 pool,	are	 highly	 resistant	 to	 induction	 of	 EAE	 as	 induced	 by	 immunization	with	myelin-derived	 antigen	 (MOG).	 Resistance	 to	 EAE	 development	 was	 T	 cell	 intrinsic,	 since	transfer	 of	 wild-type	 CD4+	 T	 cells	 into	 coronin	 1-deficient	 mice	 restored	 disease	susceptibility	and	 furthermore	depletion	of	 regulatory	T	cells	had	no	 impact	on	 the	resistance	to	EAE.	Strikingly,	leukocyte	mobilization	upon	immunization,	polyclonal	T	cell	 responses	 and	 regulatory	 T	 cell	 functions	 in	 the	 absence	 of	 coronin	 1	 were	comparable	 to	wild-type	mice.	Together	 these	results	show	that	coronin	1-deficient	mice	 are	 resistant	 to	 the	 induction	 and	 development	 of	 autoimmune	encephalomyelitis.	Coronin	 1	 is	 a	 leukocyte	 specific	 protein	 that	 in	 T	 cells	 has	 been	 implicated	 in	 a	variety	 of	 processes	 such	 as	migration,	 cell	 signaling	 and	 survival	 (36).	 Despite	 its	expression	in	all	leukocyte	subsets	with	the	exception	of	Kupffer	cells,	the	major	cell	type	affected	by	the	absence	of	coronin	1	in	vivo	are	naïve	T	cells	in	the	periphery;	in	mice	lacking	coronin	1	expression,	peripheral	T	cell	numbers	are	greatly	diminished	(19,	20,	23).	Coronin	1	is	essential	for	intracellular	calcium	mobilization	downstream	of	T	 cell	 receptor	 triggering	 and	 the	 consequent	 translocation	of	 the	NFAT	 into	 the	nucleus	(20).	This	activation	defect	of	naïve	T	cells	 lacking	coronin	1	 is	reflected	by	impaired	 proliferation	 and	 cytokine	 expression	 upon	 TCR	 stimulation	 in	 vitro.	However,	coronin	1-deficient	mice	are	capable	 to	mount	relatively	normal	antibody	responses	to	T	cell	independent	as	well	as	T	cell	dependent	antigens	(24).	The	most	striking	 effect	 of	 coronin	 1-depletion	 is	 the	 apparent	 increased	 spontaneous	apoptosis	of	naïve	T	cells	ex	vivo	(19,	20,	23).	This	observation	together	with	the	here	
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described	resistance	of	coronin	1-deficient	mice	to	EAE	development	is	in	accordance	with	the	finding	that	the	extent	of	T	cell	death	is	decisive	for	autoimmunity	(37).		The	 resistance	 of	 coronin	 1-deficient	 mice	 to	 EAE	 induction	 as	 describe	 here	 is	consistent	 with	 a	 role	 for	 coronin	 1	 in	 T	 cell	 signaling.	 Indeed,	 in	 the	 absence	 of	coronin	 1,	 MOG-specific	 T	 cell	 responses	 such	 as	 proliferation	 and	 cytokine	expression	 following	 immunization	 with	 MOG35-55	 peptide	 are	 delayed	 as	 well	 as	reduced,	strongly	suggesting	a	priming	defect	in	the	absence	of	coronin	1.	In	addition,	several	 lines	 of	 evidence	 exclude	 a	 role	 for	 coronin	 1	 in	 antigen	 processing	 and	presentation.	 These	 include	 (i)	 the	 restoration	of	 EAE	upon	 transfer	 of	 naïve,	wild-type	T	cells	as	shown	here;	(ii)	the	absence	of	any	defect	in	either	macrophage,	B	cell	and	dendritic	cell	function	(24,	25,	38);	(iii)	the	absence	of	any	gross	defects	in	thymic	selection,	a	process	that	is	heavily	dependent	on	antigen	processing	and	presentation	(19-21).	Naïve	T	cell	priming,	which	is	the	initial	step	of	an	immune	response,	usually	takes	 place	 the	 draining	 lymph	 nodes	 where	 professional	 antigen	 presenting	 cells	activate	 naïve	 T	 cells	 leading	 to	 clonal	 expansion	 and	 differentiation	 into	 cytokine-expressing	effector	T	cells.	While	peripheral	lymph	nodes	of	coronin	1-deficient	mice	are	smaller	compared	to	wild-type	mice,	the	segregation	of	T	and	B	cells	is	normal	as	well	as	the	formation	of	germinal	centers	upon	immunization	(24).	However,	 lymph	node	 swelling	 as	 an	 indication	 of	 an	 ongoing	 immune	 response	 was	 reduced	 in	coronin	1-deficient	mice	(unpublished	data),	which	might	be	due	to	impaired	lymph	node	 access	 or	 defective	T	 cell	 activation	 in	 the	 lymph	node.	However,	 it	 has	 to	 be	noted	 that	T	cell	access	 to	 lymph	nodes	may	not	be	essential	 for	EAE	development,	since	T	cell	priming	can	also	occur	in	the	spleen	or	extra-lymphoid	structures	such	as	in	liver	(39-41).	Our	results	suggest	a	more	general	activation	defect	in	coronin	1-deficient	mice,	since	splenocytes	isolated	at	several	time	points	after	immunization	with	MOG35-55	peptide	proliferated	 poorly	 upon	 ex	 vivo	 restimulation	with	 the	 same	 peptide.	 This	 finding	implies	a	diminished	in	vivo	expansion	of	MOG-specific	T	cells	in	coronin	1-deficient	mice	upon	immunization;	resulting	in	a	low	frequency	of	MOG-specific	effector	T	cells,	which	can	potentially	cause	disease.	In	line	with	the	reduced	number	of	MOG-specific	effector	 T	 cells,	 cytokine	 expression	 upon	 restimulation	with	MOG35-55	 peptide	was	reduced	in	the	absence	of	coronin	1.	In	contrast,	proliferation	induced	by	polyclonal	
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stimulation	with	 anti-CD3	 and	 anti-CD28	 antibodies	 was	 less	 affected,	 especially	 if	splenocytes	were	analyzed	at	later	time	points	after	immunization.	Thus,	it	appears	as	if	 the	 threshold	 for	polyclonal	activation	 in	vitro	 is	altered	by	 immunization	 in	vivo.	Furthermore,	 coronin	 1-deficient	 CD4+	 T	 cells	 did	 not	 display	 a	 general	 defect	 to	differentiate	into	effector	T	cells,	since	the	cytokine-profile	of	wild-type	and	coronin	1-deficient	CD4+	T	 cells	was	 comparable	after	polyclonal	 stimulation.	This	 is	 in	 line	with	 the	 finding	 that	 the	 memory	 T	 cell	 pool	 in	 coronin	 1-deficient	 mice	 is	comparable	to	wild-type	mice	(19,	20).	However,	this	does	not	explain	the	observed	increase	of	cytokine-expressing	CD4+	T	cells	after	immunization	in	vivo.	Interestingly,	expression	of	IL-4,	which	has	been	described	to	protect	from	EAE	development	(8,	9),	was	even	higher	in	coronin	1-deficient	mice.	But	since	no	MOG-specific	IL-4	secretion	was	detected,	we	rule	out	that	the	resistance	to	EAE	is	caused	by	immune	deviation	to	a	Th2	response.	Another	possible	explanation	for	the	increased	resistance	of	coronin	1-deficient	 mice	 to	 EAE	 provides	 the	 elevated	 Treg:naïve	 T	 cell	 ratio	 that	 was	observed	 in	 the	absence	of	 coronin	1.	However,	 since	 the	depletion	of	Tregs,	which	showed	 normal	 suppressive	 activity	 in	 vitro,	 did	 not	 restore	 EAE	 sensitivity,	 an	important	contribution	of	this	T	cell	subset	is	unlikely.	This	finding	supports	the	idea	that	 the	 resistance	 of	 coronin	 1-deficient	 mice	 to	 EAE	 development	 is	 primarily	 a	consequence	 of	 reduced	 naïve	 T	 cell	 number	 and/or	 impaired	 activation	 upon	immunization.		Nevertheless,	some	coronin	1-deficient	mice	developed	EAE	symptoms	and	displayed	MOG-specific	 IL-17A	 and	 IFN-g	 secretion,	 which	 was	 in	 some	 cases	 as	 high	 as	observed	 for	 wild-type	mice.	 However,	 in	 all	 of	 these	 cases	 the	 disease	 onset	 was	delayed,	even	if	in	these	few	cases	disease	severity	was	indistinguishable	from	wild-type	mice.	Consistent	with	the	delayed	disease	onset	of	 the	 few	diseased	coronin	1-deficient	mice	MOG-specific	IL-17A	and	IFN-g	secretion	was	delayed.	This	observation	might	 be	 explained	 by	 the	 important	 role	 of	 pioneer	 cells	 for	 immune	 surveillance	and	 for	 initiating	 immune	 responses	 in	 peripheral	 tissues	 (42).	 After	 priming	 and	differentiation	 in	 lymphoid	 tissues,	 myelin-specific	 effector	 T	 cells	 must	 acquire	access	to	the	non-inflamed	central	nervous	system,	where	they	act	as	pioneer	T	cells	to	induce	disease.	Recently,	the	impact	of	CCR6+	Th17	pioneer	cells	for	EAE	induction	has	been	highlighted	by	Reboldi	et	al.	 (43).	Given	 the	 strongly	 reduced	naïve	T	 cell	pool	and	the	T	cell	activation	defect	of	coronin	1-deficient	mice,	the	accumulation	of	
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threshold	numbers	of	MOG-specific	effector	T	cells	that	can	function	as	pioneer	cells	may	 be	 severely	 disturbed.	 It	 is	 well	 possible	 that	 disease	 induction	 in	 those	 few	diseased	 coronin	 1-deficient	 animals	 occurred	 through	 the	migration	 of	 only	 a	 few	pioneer	cells	in	the	central	nervous	system.	Indeed,	our	results	suggest,	that	coronin	1-deficient	 MOG-reactive	 T	 cells	 once	 activated	 and	 arrived	 in	 the	 central	 nervous	system,	have	the	same	potential	than	wild-type	T	cells	to	activate	local	tissue	cells	and	mediate	 the	 recruitment	 of	 further	 immune	 cells.	 In	 agreement	 with	 this	 idea,	 we	found	 a	 clear	 correlation	 between	 EAE	 symptoms	 and	 the	 extent	 of	 immune	 cell	infiltration.	The	hypothesis	of	a	 threshold	number	of	MOG-specific	T	cells	 is	 further	supported	by	our	observation	that	transfer	of	one	and	five	million	of	wild-type	CD4+	T	cells	 from	 naïve	 mice	 did	 not	 increase	 EAE	 susceptibility,	 while	 ten	 million	 had	already	a	slight	effect	and	20	million	transferred	CD4+	T	cells	did	break	resistance	of	coronin	 1-deficient	 mice	 to	 EAE	 induction.	 In	 line	 with	 this,	 it	 has	 been	 shown	 in	rodent	models	of	EAE	that	modulation	of	the	CD4+	T	cell	pool,	which	is	available	for	activation,	 by	 administration	 of	 anti-CD4-antibodies,	 either	 depleting	 or	 inhibitory,	prevented	development	of	EAE	(44-46).		Taken	 together,	 the	 results	 presented	 here	 demonstrate	 a	 hitherto	 unknown	 and	specific	 role	 for	 the	 naïve	 T	 cell	 pool	 1	 in	 shaping	 CD4+	 T	 cell	 responses	 towards	autoantigens	 and	 reveal	 coronin	 1	 as	 a	 crucial	 molecule	 in	 the	 induction	 of	autoimmune	encephalomyelitis.		
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Figure	legends		
Figure	 1.	 EAE	pathology	 in	 the	 presence	 and	 absence	 of	 coronin	 1.	 Coronin	 1-deficient	(coro1-/-)	and	wild-type	(WT)	mice	were	immunized	with	MOG35-55	peptide	in	 CFA	 to	 induce	 active	 EAE.	 A-E,	 Disease	 development	 and	 progression	 were	monitored	over	time	using	the	scoring	system	described	in	Material	and	Methods.	A,	Mean	 clinical	 score	 ±	 S.E.M	 of	 3	 independent	 experiments	 (n	 =	 20).	 B,	 Mean	 body	weight	±	 S.E.M	of	 2	 independent	 experiments	 (n	=	10).	 C,	D,	Maximal	 clinical	 score	and	day	of	disease	onset	are	displayed	for	every	single	mouse	together	with	the	mean.	The	 numbers	 included	 in	 the	 graphs	 represent	 the	 mean	 ±	 SD	 calculated	 only	 for	animals	showing	signs	of	EAE	(5	independent	experiments,	n	=	33	and	32).	E,	Average	disease	 incidence,	 results	 of	 5	 independent	 experiments	 are	 shown.	 F,	Immunohistological	 analyses	 of	 spinal	 cord	 sections	 (lumbar)	 at	 end	 of	 the	experiment	 and	 quantification	 of	 lesion	 sizes	 (%	 of	 area	 of	 the	 whole	 spinal	 cord	cross	 section)	 of	 the	 individual	 animals	 (nCoro1-/-	 =	 15,	 nWT	 =	 14).	 Representative	F4/80	 staining	 of	wild-type	 and	 coronin	 1-deficient	mice	 are	 shown	 scale	 bar:	 500	
µm.	The	corresponding	maximal	clinical	score	is	displayed.		
Figure	2.	Immune	response	of	wild-type	and	coronin	1-deficient	mice	upon	EAE	
induction.	A-C,	The	frequency	of	leukocyte	subsets	in	blood	of	coro1-/-	and	WT	mice	was	 analyzed	 by	 flow	 cytometry	 at	 the	 indicated	 time	 points	 before	 and	 after	immunization	 with	 MOG35-55	 peptide	 in	 CFA.	 Total	 leukocyte	 (A),	 granulocyte	 (B),	lymphocyte	 (B)	 and	 CD4+	 T	 cell	 (C)	 counts	 per	 ml	 blood	 and	 fold	 change	 upon	immunization	 are	 shown	 in	 the	 graphs.	 Representative	 FACS	 dot	 plots	 depicting	forward	versus	sideward	scatter	(B)	and	CD4	versus	GFP	(C,	coro1-/-:	coronin	1	gene	is	disrupted	by	insertion	of	GFP)	of	blood	samples	of	coro1-/-	and	WT	mice	before	and	at	day	 six	 after	 immunization	are	 shown.	The	graphs	 summarize	 the	 results	of	 two	independent	experiments,	presented	as	mean	±	SD	(n	=	10).	D,	The	frequency	of	IFN-
g,	 IL-17A	 and	 IL-4-expressing	 cells	 among	 CD4+	 T	cells	 was	 analyzed	 by	 flow	cytometry.	Splenocytes	were	re-stimulated	ex	vivo	with	anti-CD3	and	anti-CD28	in	the	presence	 of	 brefeldin	 A	 and	 the	 cytokine	 expression	was	 analyzed	 by	 intracellular	staining	and	 flow	cytometry.	Representative	FACS	dot	blots	 (gated	on	CD4+	T	cells)	are	 shown	 for	MOG-immunized	 coronin	1-deficient	 and	wild-type	mice.	The	graphs	
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show	cell	count	of	IFN-g+,	IL-17A+	and	IL-4+	CD4+	T	cells	of	naïve	mice	and	mice	that	have	been	immunized	to	induce	active	EAE	40	days	before	the	analysis	(naïve	mice:	n	=	7;	 immunized	mice	n=18	 for	wt	and	n=20	 for	coro1-/-).	Results	of	 individual	mice	and	the	mean	are	shown.	ns,	not	significant		
Figure	3.	MOG-specific	immune	responses	of	wild-type	and	coronin	1-deficient	
mice.	 Active	EAE	was	 induced	 in	 coronin	1-deficient	 (coro1-/-)	 and	wild-type	 (WT)	mice	and	MOG-specific	responses	were	analyzed	ex	vivo	during	EAE	development	and	at	 peak	 of	 the	 disease	 (corresponding	 to	 day	 6,	 12	 and	 16)	 in	 one	 experiment	 and	during	chronic	disease	state	at	day	40	in	two	other	experiments.	A,	IFN-g	and	IL-17A	concentration	 in	 the	 supernatant	 of	 MOG35-55	 peptide-stimulated	 splenocytes	(50µg/ml	for	48	hours)	were	analyzed	by	ELISA.	Each	symbol	represents	data	from	one	mouse.	Animal	that	developed	signs	of	EAE	are	labeled	with	*.	B,	Splenocytes	of	individual	mice	were	stimulated	 in	 vitro	with	 increasing	concentrations	of	MOG35-55	peptide	 or	 anti-CD3/anti-CD28	 antibodies.	 After	 72	 hours	 of	 culture	 the	 cells	were	pulsed	 with	 [3H]-thymidin	 and	 harvested	 16	 hours	 later	 for	 measurement	 of	radioisotope	incorporation.	Mean	counts	per	minute	(cpm)	±	SD	or	cpm	of	individual	mice	are	depicted.	n.d.,	not	detectable;	ns,	not	significant;	n	=	5	(day	6,	12,	16),	n	=	10	(day	40)		
Figure	4.	Immune	cell	infiltration	in	the	spinal	cords	of	wild-type	and	coronin	1-
deficient	 mice	 analyzed	 by	 immunofluorescence.	 Spinal	 cord	 sections	 obtained	from	 wild-type	 and	 coronin	 1-deficient	 mice	 at	 the	 indicated	 time	 points	 after	immunization	were	processed	for	immunofluorescence	staining	using	antibodies	for	CD4,	 coronin	 1	 and	 F4/80.	 Note	 that	 no	 infiltration	 of	 immune	 cells	was	 observed	before	disease	onset	 (day	6),	but	at	day	12	and	16,	a	massive	 infiltration	of	CD4+	T	cells,	F4/80	positive	macrophages	and	coronin	1	positive	cells	was	detected	in	wild-type	mice	(arrowheads).	In	contrast,	no	infiltration	was	visible	in	coronin	1-deficient	mice	on	neither	time	point.	Representative	stainings	are	shown.	Rectangles	mark	the	regions	of	which	day	12	inlets	were	taken.	(Scale	bar	d6,	d12	and	d16	=	500µm,	Scale	bar	d12	inlet	=	100µm;	n=5	per	time	point	(day	6,	12,	16).		
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Figure	5.	Active	EAE	analyzed	following	transfer	of	wild-type	CD4+	T	cells	 into	
coronin	 1-deficient	mice.	 Twenty	million	MACS-sorted	 CD4+	 T	 cells	 isolated	 from	wild-type	 mice	 were	 transferred	 i.v.	 one	 day	 prior	 immunization	 with	 MOG35-55	peptide.	Wild-type	and	coronin	1-deficient	mice	injected	with	PBS	served	as	controls.	The	clinical	score	over	time	is	depicted	for	each	individual	mouse	(n	=	7	or	8).		
Figure	6.	Importance	of	regulatory	T	cells	in	wild-type	and	coronin	1-deficient	
mice	with	and	without	EAE	 induction.	 The	 frequency	 and	 suppressive	 activity	 of	regulatory	T	cells	(Tregs)	was	analyzed	ex	vivo	as	well	as	in	vivo.	A,	The	frequency	and	number	 of	 CD25	 and	 Foxp3-expressing	 CD4+	 splenocytes	 was	 analyzed	 by	 flow	cytometry.	 Representative	 FACS	 dot	 plots	 gated	 for	 CD4	 are	 shown.	 Each	 symbol	represents	data	 from	one	mouse	 (n	=	8	 or	9	 /	 2	 independent	 experiments).	B,	 The	suppressive	 capacity	 of	 CD25+CD4+	 T	 cells	 from	 coronin	 1-deficient	 and	 wild-type	mice	 was	 analyzed	 with	 a	 in	 vitro	 suppression	 assay.	 CD25-CD4+	 responders	 were	isolated	 from	 coronin	 1-deficient	 and	 wild-type	 mice.	 The	 ratio	 of	 responders	 to	Tregs	 is	 depicted.	 Results	 are	 expressed	 as	 the	 mean	 ±	 SD.	 [3H]-thymidine	incorporation	from	triplicate	cultures.	One	out	of	two	experiments	is	shown.	C,	CD25+	cells	were	depleted	in	vivo	by	i.p.	administration	of	anti-CD25	antibody	(PC61)	three	and	 five	 days	 prior	 immunization	 with	MOG35-55	 peptide.	 The	 control	 groups	 were	immunized	with	MOG35-55	peptide	but	did	not	receive	antibodies.	Mean	clinical	score	and	mean	body	weight	±	S.E.M.,	maximal	clinical	disease	score	and	the	day	of	disease	onset	 for	 individual	 mice	 are	 displayed	 together	 with	 the	 mean	 and	 the	 EAE	incidence.	(n	=	7	or	6,	for	non-PC61-treated	wt);	ns,	not	significant			






